Targeted Multidomain Intervention for Concussion
(T-MD Trial)
Trial Summary
What is the purpose of this trial?
Objective: This 3-year multisite RCT will determine the effectiveness of a targeted multidomain intervention (T-MD) (anxiety/mood, cognitive, migraine, ocular, vestibular; and sleep, autonomic) compared to usual care (behavioral management) in military-aged civilians with complex mTBI.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Targeted Multidomain Intervention for Concussion?
How is the Targeted Multidomain Intervention for Concussion treatment different from other treatments?
The Targeted Multidomain Intervention for Concussion is unique because it uses a personalized, dynamic approach tailored to each individual's symptoms, focusing on psychoeducation and cognitive strategy instruction to address cognitive impairments. This treatment adapts based on the patient's progress and perceived helpfulness of strategies, making it more flexible and responsive compared to standard treatments.13467
Research Team
Anthony P Kontod, PhD
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for military-aged civilians (18-49) who've had a mild traumatic brain injury (mTBI) with symptoms like confusion, dizziness, or memory issues. They must have been diagnosed within the past 8 days to 6 months and have a Glascow coma scale score of at least 13. Exclusions include those with certain vestibular or neurological disorders, severe TBI history, pregnancy, legal actions related to mTBI, or previous participation in this study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Comprehensive multidomain evaluation of symptoms and impairment to inform adjudication process
Treatment
Participants receive targeted multidomain interventions or usual care for complex mTBI
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Behavioral Management
- Targeted Multidomain
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
United States Department of Defense
Collaborator
Inova Health Care Services
Collaborator